# E135: IL17 and a GLP1?

Page: https://stenobird.com/podcast/the-evidence-based-rheumatology-podcast-1130175/e135-il17-and-a-glp1
Text version: https://stenobird.com/podcast/the-evidence-based-rheumatology-podcast-1130175/e135-il17-and-a-glp1.md
Podcast: [The Evidence Based Rheumatology Podcast](https://stenobird.com/podcast/the-evidence-based-rheumatology-podcast-1130175)
Published: 2026-04-30T13:43:00+00:00
Episode link: https://msputman.podbean.com/e/e135-il17-and-a-glp1/
Audio file: https://mcdn.podbean.com/mf/web/am5pivh8e7h3r7ne/e135.mp3
Processing state: not_requested
JSON: https://stenobird.com/v1/public/podcasts/the-evidence-based-rheumatology-podcast-1130175/episodes/e135-il17-and-a-glp1
Duration seconds: 663

## Resource

Really interesting study this week comparing the IL17 inhibitor ixekizumab WITH the GLP1 inhibitor tirzepatide to ixekizumab alone. Raises some interesting questions about what worked here and whether or not it matters how it worked. Paper: https://acrjournals.onlinelibrary.wiley.com/doi/10.1002/art.70134 Newsletter: http://autoimmunedevreport.com/

## Actions

- request_transcript: `POST https://stenobird.com/v1/public/podcasts/the-evidence-based-rheumatology-podcast-1130175/episodes/e135-il17-and-a-glp1/transcription-requests` — Idempotently request low-priority transcript generation for this episode.
- read_markdown: `GET https://stenobird.com/podcast/the-evidence-based-rheumatology-podcast-1130175/e135-il17-and-a-glp1.md` — Read the agent-friendly Markdown representation of this episode resource.

A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed.

## Transcript

Full transcripts are not published on public pages unless there is a clear rights basis.